Clinical trials
Aortic Valve Stenosis trials with no applicable phase and unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
60 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 2 |
| 2011 | 1 |
| 2012 | 2 |
| 2013 | 1 |
| 2014 | 4 |
| 2015 | 4 |
| 2016 | 7 |
| 2017 | 4 |
| 2018 | 9 |
| 2019 | 6 |
| 2020 | 4 |
| 2021 | 7 |
| 2022 | 3 |
| 2023 | 2 |
| 2024 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 60 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| BC Centre for Improved Cardiovascular Health | 2 |
| Deutsches Herzzentrum Muenchen | 2 |
| Direct Flow Medical, Inc. | 2 |
| Erasmus Medical Center | 2 |
| Shanghai MicroPort CardioFlow Medtech Co., Ltd. | 2 |
| Anteris Technologies Ltd. | 1 |
| Assistance Publique - Hôpitaux de Paris | 1 |
| Centro Cardiologico Monzino | 1 |
| Ceric Sàrl | 1 |
| Cliniques universitaires Saint-Luc- Université Catholique de Louvain | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Aortic Valve Stenosis | 60 |
| Aortic Valve Disease | 6 |
| Aortic Valve Insufficiency | 6 |
| Coronary Artery Disease | 6 |
| Cardiovascular Diseases | 5 |
| Heart Valve Diseases | 5 |
| Heart Diseases | 3 |
| Mitral Valve Insufficiency | 3 |
| Stroke | 3 |
| Anxiety Disorders | 1 |
Trials
Showing 1 to 25 of 60. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.